<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36670030</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8989</ISSN><JournalIssue CitedMedium="Internet"><Volume>160</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Medicina clinica</Title><ISOAbbreviation>Med Clin (Barc)</ISOAbbreviation></Journal><ArticleTitle>Persistent olfactory dysfunction in mild COVID-19 patients: A descriptive study of the characteristics and association with other symptoms.</ArticleTitle><Pagination><StartPage>347</StartPage><EndPage>351</EndPage><MedlinePgn>347-351</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medcli.2022.11.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0025-7753(22)00674-1</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Post-COVID olfactory dysfunction continues to be studied due to the controversy of the mechanisms involved. The aim was to investigate the olfactory dysfunctions in association with other post-COVID symptoms.</AbstractText><AbstractText Label="MATERIAL AND METHODS">Observational, descriptive and single-center study. The patients had confirmed mild COVID-19 and subjective olfactory dysfunction of more than a month of evolution, which was assessed by Sniffin' Sticks Olfactory Test.</AbstractText><AbstractText Label="RESULTS">A total of 86 patients participated. The mean age was 37.2 years (SD 9.82). 70.9% reported parosmia and 46.5% symptoms of brain fog. A pathological test result was obtained in 72.1% of the participants. The most failed pen was 11 (apple) in 76.7%. Anosmia of pen 15 (anise) was reported more frequently in 24.4% and cacosmia of pen 9 (garlic) in 27.9%. We observed a significant association between patients who reported parosmias and brain fog (RR 2.18; p=0.018), also between parosmia and phantosmia (RR 6.042; p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION">There is some pathological selectivity for certain test pens, a higher prevalence of cognitive symptoms and many patients with combined parosmia and brain fog.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a-Mel&#xe9;ndez</LastName><ForeName>David Dylan</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Toledo, Av. R&#xed;o Guadiana, 45007 Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales-Casado</LastName><ForeName>Mar&#xed;a Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Toledo, Av. R&#xed;o Guadiana, 45007 Toledo, Spain. Electronic address: mimorales@sescam.jccm.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintana Castro</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Toledo, Av. R&#xed;o Guadiana, 45007 Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsal Alonso</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Toledo, Av. R&#xed;o Guadiana, 45007 Toledo, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Clin (Barc)</MedlineTA><NlmUniqueID>0376377</NlmUniqueID><ISSNLinking>0025-7753</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N">La alteraci&#xf3;n olfatoria post-COVID contin&#xfa;a en estudio por la controversia sobre los mecanismos implicados. El objetivo de este estudio es caracterizar las alteraciones olfatorias y su relaci&#xf3;n con otros s&#xed;ntomas post-COVID.</AbstractText><AbstractText Label="MATERIAL Y M&#xc9;TODOS">Estudio unic&#xe9;ntrico, observacional y descriptivo. Los pacientes tuvieron infecci&#xf3;n por COVID-19 leve confirmada y disfunci&#xf3;n olfatoria subjetiva de m&#xe1;s de un mes de evoluci&#xf3;n, evaluada con el <i>Sniffin&#x2019; Sticks Olfatory Test.</i></AbstractText><AbstractText Label="RESULTADOS">Se seleccionaron 86 pacientes. La edad media fue de 37,2 a&#xf1;os (DE 9,82). El 70,9% refirieron parosmia y el 46,5% niebla mental. Se obtuvo un test patol&#xf3;gico en el 72,1% de los participantes. El l&#xe1;piz m&#xe1;s fallado fue el n&#xfa;mero 11 (manzana), en el 76,7%. La anosmia fue reportada m&#xe1;s frecuentemente con el l&#xe1;piz 15 (an&#xed;s) y la cacosmia con el l&#xe1;piz 9 (ajo) en el 27,9%. Observamos una asociaci&#xf3;n significativa entre pacientes que refieren parosmias y niebla mental (RR 2,18; p&#xa0;=&#xa0;0,018) y entre parosmia y fantosmia (RR 6,042; p&#xa0;&lt;&#xa0;0,001).</AbstractText><AbstractText Label="CONCLUSI&#xd3;N">Se observa anosmia y cacosmia selectiva para algunos olores testados. Hay una alta prevalencia de s&#xed;ntomas cognitivos, m&#xe1;s frecuentes en pacientes con parosmia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alteraci&#xf3;n olfatoria</Keyword><Keyword MajorTopicYN="N">Anosmia</Keyword><Keyword MajorTopicYN="N">Brain fog</Keyword><Keyword MajorTopicYN="N">COVID persistente</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Niebla mental</Keyword><Keyword MajorTopicYN="N">Olfactory dysfunction</Keyword><Keyword MajorTopicYN="N">Parosmia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>22</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36670030</ArticleId><ArticleId IdType="pmc">PMC9800808</ArticleId><ArticleId IdType="doi">10.1016/j.medcli.2022.11.018</ArticleId><ArticleId IdType="pii">S0025-7753(22)00674-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasser Peramo-&#xc1;lvarez F.P., L&#xf3;pez-Z&#xfa;&#xf1;iga M.&#xc1;., L&#xf3;pez-Ruz M.&#xc1;. Medical sequels of COVID-19. Med Clin (Barc) 2021;157:388&#x2013;394. doi: 10.1016/j.medcli.2021.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2021.04.023</ArticleId><ArticleId IdType="pmc">PMC8491931</ArticleId><ArticleId IdType="pubmed">34632064</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra S., Kolappa K., Prasad M., Radhakrishnan D., Thakur K.T., Solomon T., et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology. 2021;97:e2269&#x2013;e2281. doi: 10.1212/WNL.0000000000012930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012930</ArticleId><ArticleId IdType="pmc">PMC8665434</ArticleId><ArticleId IdType="pubmed">34635561</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., Beckers E., Mustin V., Ducarme M., Journe F., et al. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021;290:451&#x2013;461. doi: 10.1111/joim.13209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13209</ArticleId><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Sekinger B., Wolf S.R., Pauli E., Kobal G. &#x201c;Sniffin&#x201d; Sticks&#x2019;: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22:39&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9056084</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya J., Islam M.A., Abdullah B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): a meta-analysis of 27,492 patients. Laryngoscope. 2021;131:865&#x2013;878. doi: 10.1002/lary.29286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29286</ArticleId><ArticleId IdType="pmc">PMC7753439</ArticleId><ArticleId IdType="pubmed">33219539</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Losada M.L., Bouhaben J., Delgado-Lima A.H. Development of the Spanish version of Sniffin's sticks olfactory identification test: normative data and validity of parallel measures. Brain Sci. 2021;11:1&#x2013;21. doi: 10.3390/brainsci11020216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11020216</ArticleId><ArticleId IdType="pmc">PMC7916642</ArticleId><ArticleId IdType="pubmed">33578970</ArticleId></ArticleIdList></Reference><Reference><Citation>Audouze K., Tromelin A., le Bon A.M., Belloir C., Petersen R.K., Kristiansen K., et al. Identification of odorant&#x2013;receptor interactions by global mapping of the human odorome. PLoS ONE. 2014;9:e93037. doi: 10.1371/journal.pone.0093037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093037</ArticleId><ArticleId IdType="pmc">PMC3973694</ArticleId><ArticleId IdType="pubmed">24695519</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221&#x2013;224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>DosSantos M.F., Devalle S., Aran V., Capra D., Roque N.R., Coelho-Aguiar J.d.M., et al. Neuromechanisms of SARS-CoV-2: a review. Front Neuroanat. 2020;14:37. doi: 10.3389/fnana.2020.00037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2020.00037</ArticleId><ArticleId IdType="pmc">PMC7308495</ArticleId><ArticleId IdType="pubmed">32612515</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray P.B., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81:813&#x2013;821. doi: 10.1128/JVI.02012-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02012-06</ArticleId><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>